ROBERT PHILIBERT, MD PHD
Psychiatric at Hawkins Dr, Iowa City, IA
License number
Iowa 28133
Category
Neurology
Type
Neurology
License number
Iowa 28133
Category
Psychiatric
Type
Psychiatry
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 353-4986
(319) 353-3007 (Fax)
(319) 353-3007 (Fax)
Organization information
See more information about ROBERT PHILIBERT at bizstanding.comRobert Philibert MD,PHD
200 Hawkins Dr, Iowa City, IA 52242
Industry:
Psychiatrist, Neurologist
Phone:
(319) 356-1616 (Phone)
Robert Alan Philibert
Robert Philibert MD
500 Newton Rd #2-126D, Iowa City, IA 52242
Categories:
Psychiatry Physicians
Phone:
(319) 353-4986 (Phone)
Professional information
Robert Alan Philibert, Iowa City IA
Specialties:
Psychiatry, Neurology
Work:
University Of Iowa Hospital & Clinic
200 Hawkins Dr, Iowa City, IA 52243
200 Hawkins Dr, Iowa City, IA 52243
Education:
University of Iowa (1989)
Dr. Robert Philibert, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
Iowa City Office
200 Hawkins Dr, Iowa City 52242
(319) 356-1616 (Phone), (319) 384-7899 (Fax)
200 Hawkins Dr, Iowa City 52242
(319) 356-1616 (Phone), (319) 384-7899 (Fax)
Certifications:
Psychiatry, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Iowa City Office
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
University of Ia Roy J & L Carver Com
Graduated: 1989
University Iowa Hosps and Clinics
University of Ia Roy J & L Carver Com
Graduated: 1989
University Iowa Hosps and Clinics
Identification Of Polymorphisms In The Pctg4 Region Of Xq13
US Patent:
6566061, May 20, 2003
Filed:
Jan 26, 2000
Appl. No.:
09/491356
Inventors:
Robert A. Philibert - Iowa City IA
Edward I. Ginns - Bethesda MD
Lynn Delisi - Stony Brook NY
Edward I. Ginns - Bethesda MD
Lynn Delisi - Stony Brook NY
Assignee:
The University of Iowa, as represented by the University of Iowa Research Foundation - Iowa City IA
The United States of America as represented by the Department of Health and Human Services - Washington DC
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C07H 2104
US Classification:
435 6, 435 912, 536 231, 536 243, 536 2433
Abstract:
Nucleic acid sequences within the q13 region of the X chromosome having polymorphisms associated with neuropsychiatric disorders and associated conditions are disclosed herein. One polymorphism occurs within the coding region of the HOPA gene and introduces a four amino acid insertion into a putative OPA domain, a domain which has been shown to be involved in tissue specific expression. Compositions including nucleic acids having these polymorphisms and antibodies to polymorphic regions within proteins encoded in the PCTG4 region are provided. Methods of using the information and nucleic acid sequences disclosed herein for the diagnosis and assessment of pathologies associated with neuropsychiatric disorders and associated conditions are also provided.
Robert A Philibert, Iowa City IA
Specialties:
Psychiatrist
Address:
200 Hawkins Dr, Iowa City, IA 52242
Compositions And Methods For Detecting Predisposition To A Substance Use Disorder
US Patent:
8637652, Jan 28, 2014
Filed:
Oct 28, 2011
Appl. No.:
13/284425
Inventors:
Robert Philibert - Iowa City IA, US
Anup Madan - Bellevue WA, US
Anup Madan - Bellevue WA, US
International Classification:
C07H 21/02, G01N 33/44
US Classification:
536 231, 436 94
Abstract:
The present invention provides screening kits, compositions, and diagnostic methods for determining whether a subject has a predisposition to, or likelihood of having, a substance use disorder by determining a nucleic acid methylation profile from a biological sample from the subject, wherein a given profile indicates that the subject has a predisposition to a substance use disorder.
Regulation Of The Serotonin Reuptake Transporter And Disease
US Patent:
2007024, Oct 25, 2007
Filed:
Dec 22, 2006
Appl. No.:
11/644198
Inventors:
Robert Philibert - University Heights IA, US
Anup Madan - Bellevue WA, US
Anup Madan - Bellevue WA, US
International Classification:
C12Q 1/68, C12N 5/00
US Classification:
424093700, 435325000, 435375000, 435006000, 536023100
Abstract:
Described herein is a CpG island in the 5′ region of the 5HTT gene that contains an alternative exon 1 and promoter for 5HTT. Methylation at this CpG island is associated with decreased levels of 5HTT mRNA, and this effect is evident when 5HTTLPR genotype is taken into account. Thus, this methylation status indicates 5HTT mRNA production, which serves as an indicator for the expression of the transporter and of a subject's vulnerability to diseases related to serotonergic activity. Accordingly, certain embodiments of the present invention provide diagnostic methods for determining whether a subject has, or is at risk for developing, a disease associated with serotonergic activity.
Compositions And Methods For Detecting Predisposition To A Substance Use Disorder Or To A Mental Illness Or Syndrome
US Patent:
2007029, Dec 20, 2007
Filed:
May 7, 2007
Appl. No.:
11/800629
Inventors:
Robert Philibert - University Heights IA, US
Anup Madan - Bellevue WA, US
Anup Madan - Bellevue WA, US
International Classification:
C12Q 1/68, G01N 33/00
US Classification:
435006000, 436094000
Abstract:
The present invention provides screening kits, compositions, and diagnostic methods for determining whether a subject has a predisposition to, or likelihood of having, a substance use disorder or mental illness or syndrome by determining a nucleic acid expression profile from a biological sample from the subject, wherein a given profile indicates that the subject has a predisposition to a substance use disorder or mental illness or syndrome.
Regulation Of The Serotonin Reuptake Transporter And Disease
US Patent:
2011031, Dec 29, 2011
Filed:
Apr 15, 2011
Appl. No.:
13/087993
Inventors:
Robert Philibert - Iowa City IA, US
Anup Madan - Iowa City IA, US
Anup Madan - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Described herein is a CpG island in the 5′ region of the 5HTT gene that contains an alternative exon 1 and promoter for 5HTT. Methylation at this CpG island is associated with decreased levels of 5HTT mRNA, and this effect is evident when 5HTTLPR genotype is taken into account. Thus, this methylation status indicates 5HTT mRNA production, which serves as an indicator for the expression of the transporter and of a subject's vulnerability to diseases related to serotonergic activity. Accordingly, certain embodiments of the present invention provide diagnostic methods for determining whether a subject has, or is at risk for developing, a disease associated with serotonergic activity.